Life Science & Biotech

ARTICLES

2015 Forty Under 40: Tristan Coram

Tristan Coram, 34, research scientist for Dow AgroSciences, works to boost global crop production.
Read More

HIP 2.0 approval means 40,000 Hoosiers must end their Obamacare coverage

An estimated 40,000 Hoosiers who already bought health insurance on the Obamacare exchanges now must end those plans and enroll in the expanded Healthy Indiana Plan. Otherwise, they'll be on the hook to pay back thousands of dollars in Obamacare tax credits.
Read More

Health VC dollars tripled in Indiana

Indiana’s health care companies attracted $103.8 million in investments last year, the highest total since attracting 2007. However, all but $3 million of last year’s investments came during the first six months of the year and Indiana continued to lag other Midwest states.
Read More

The Billion Dollar Decision

When the U.S. Supreme Court hands down its ruling on Obamacare’s tax credits, it could zap nearly $1 billion from Hoosiers’ finances. In fact, Hoosiers buyers on Obamacare's exchanges have more to lose, as a percentage of their incomes, than the residents of all states other than Alaska and Mississippi.
Read More

CEO Roundup: We’re not your father’s health care company anymore

The CEOs of Anthem, Lilly, Zimmer and Hill-Rom tried to woo investors at the J.P. Morgan Healthcare conference by stressing how they're broadening business beyond plain-old insurance, pharmaceuticals, implants and hospital beds.
Read More

We're at tipping point of health care becoming a real marketplace

Nearly half of all Hoosier workers covered by employer health plans are now enrolled in high-deductible, consumer-directed health plans, according to a new survey. That means the state is about to pass the point of no return on transforming health care into a real marketplace.
Read More

Obamacare's effects on Lilly: Modest pain, no gain

Since Obamcare was expected to boost insurance coverage nationally by 32 million people, drugmakers like Eli Lilly and Co. stood to benefit. But it’s not working out that way. At least not for Lilly.
Read More

UPDATE: Lilly forecasts earnings below analyst expectations

The Indianapolis-based drugmaker said its long-term strategy is on track, but predicted sales this year would be $20.3 billion to $20.8 billion, a shade below what Wall Street was expecting.
Read More

Hoosier hospitals create new tool to help health care shoppers

Recognizing that more and more Hoosier patients are trying to shop for health care, the Indiana Hospital Association has created a web tool with price and quality information for all hospitals around the state. But bigger changes to the health care system will be needed before consumers have the kind of information they expect in other industries.
Read More

Study: Nursing home building boom is costing state millions

The state Medicaid program will pay $24 million more due to the nursing home building boom that occurred in 2014, according to an analysis by accounting firm Myers & Stauffer. The nursing home industry will use that figure to once again argue for halt to new construction.
Read More